nutrients-logo

Journal Browser

Journal Browser

Vitamin D Receptor in Human Health and Disease—2nd Edition

A special issue of Nutrients (ISSN 2072-6643). This special issue belongs to the section "Micronutrients and Human Health".

Deadline for manuscript submissions: closed (21 September 2023) | Viewed by 7274

Special Issue Editor


E-Mail Website
Guest Editor
Vascular and Renal Translational Research Group, Institut de Recerca Biomèdica de Lleida IRBLleida, 25198 Lleida, Spain
Interests: vitamin D; calcium; phosphate; potassium; chronic kidney disease; mineral metabolism; atherosclerosis; dyslipidemia
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Vitamin D is a seco-steroid hormone that has long been known for its important role in regulating body levels of calcium and phosphorus, and in the mineralization of bone. In addition to its endocrine effects, vitamin D plays important autocrine/paracrine roles. The last step in the activation of vitamin D, the hydroxylation on carbon 1, mainly occurs in the kidney. However, extrarenal sites showing 1 alpha-hydroxylase activity have also been found. The hormonally active form of vitamin D (1,25(OH)2D3 or calcitriol) mediates its biological effects by binding to the vitamin D receptor, which then translocates to the nucleus of the cell and binds to specific DNA sites to modify the expression of target genes. After activation of the receptor, the protein changes its tridimensional conformation; this change is the key process to mediate its nuclear actions. Several steps take place to increase or decrease the transcription rate of a target gene. First, homodimerization of the vitamin D receptor or heterodimerization with the retinoid X receptor allows the complex to enter the nucleus and bind to DNA. Then, several proteins are recruited to the complex that either increase or decrease chromatin condensation, thus acting like co-repressors or co-activators, respectively, finally decreasing or increasing the target gene transcription. The co-activators bind several extra proteins that build a bridge to the basal transcription machinery.

In recent decades, a number of basic and clinical studies have pointed to the important role that vitamin D plays in various physiological and pathological processes throughout the body. Thus, it has been shown that vitamin D exerts its pleiotropic effects in a variety of target cells, where it is involved in a wide array of new functions that are unrelated to its actions on mineral metabolism. For instance, vitamin D has been involved in the regulation of vascular smooth muscle cell proliferation and calcification, in the modulation of the renin–angiotensin system and, in general, in cardiovascular health. Furthermore, Vitamin D negatively regulates the growth of breast, prostate, and colon cancer cells. It is also known that vitamin D functions as a general suppressor of the immune system, including the activated B- and T- lymphocytes, and especially the T-helper cells. Some studies also show that 1,25(OH)2D3 affects several major endocrine processes, such as TRH/TSH action and pancreatic insulin secretion, with the subsequent regulation of glucose homeostasis, and likewise regulates key hepatic genes affecting lipid metabolism. Therefore, vitamin D can be considered an essential nutrient affecting many pathways of mammalian homeostasis.

This Special Issue invites original research and review papers on the role of vitamin D in health and disease.

Dr. Jose M. Valdivielso
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vitamin D
  • calcitriol
  • vitamin D receptor
  • diabetes
  • cardiovascular risk
  • immunity

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

12 pages, 297 KiB  
Article
Association of Vitamin D Receptor Gene Polymorphisms with Cardiometabolic Phenotypes in Hispanics: A Life Course Approach
by Carrie S. Standage-Beier, Luis A. Garcia, Eleanna De Filippis, Gabriel Q. Shaibi, Lawrence J. Mandarino and Dawn K. Coletta
Nutrients 2023, 15(9), 2118; https://doi.org/10.3390/nu15092118 - 28 Apr 2023
Cited by 1 | Viewed by 2034
Abstract
The vitamin D receptor (VDR) is vital for maintaining calcium and phosphate balance and regulating bone metabolism. Recent research has suggested that VDR also plays an essential role in metabolic diseases. Previous studies on non-Hispanic whites have shown that VDR single nucleotide polymorphisms [...] Read more.
The vitamin D receptor (VDR) is vital for maintaining calcium and phosphate balance and regulating bone metabolism. Recent research has suggested that VDR also plays an essential role in metabolic diseases. Previous studies on non-Hispanic whites have shown that VDR single nucleotide polymorphisms (SNP) are associated with cardiometabolic phenotypes. However, the association between VDR SNPs and cardiometabolic traits in Hispanics remains unclear. This study investigated the association between VDR SNPs and cardiometabolic phenotypic data in self-reported Hispanics (n = 1610) from the Arizona Insulin Resistance registry and Sangre Por Salud Biobank. The study population was predominantly female (66.4%) with a mean age of 40 ± 14 years (n = 121 <18 years) and an average body mass index (BMI) of 29.8 ± 6.3 kg/m2. We performed a genotyping association analysis of VDR SNPs (Taq1-rs731236, Fok1-rs2228570 and Apa1-rs7975232) with cardiometabolic traits using linear regression models. The results showed that Taq1 and Apa1 were strongly associated with systolic blood pressure (SBP) in children (<18 years), while Fok1 was associated with measures of adiposity, including fat mass, waist circumference, and BMI. In age-stratified adult (≥18 years) models, Taq1 was strongly associated with hemoglobin A1c, while Apa1 was associated with BMI and fasting glucose. Fok1 had no significant associations in the adult models. In conclusion, the VDR SNPs were associated with several cardiometabolic phenotypes in this Hispanic sample, but the type and strength of the associations varied by age group. Full article
(This article belongs to the Special Issue Vitamin D Receptor in Human Health and Disease—2nd Edition)
Show Figures

Graphical abstract

Review

Jump to: Research

13 pages, 584 KiB  
Review
Vitamin D and Chronic Kidney Disease Association with Mineral and Bone Disorder: An Appraisal of Tangled Guidelines
by Jordi Bover, Elisabet Massó, Laia Gifre, Carlo Alfieri, Jordi Soler-Majoral, Maria Fusaro, Jordi Calabia, Rosely Rodríguez-Pena, Néstor Rodríguez-Chitiva, Víctor López-Báez, Maya Sánchez-Baya, Iara da Silva, Armando Aguilar, Misael C. Bustos, Natacha Rodrigues, Jonathan S. Chávez-Iñiguez, Gregorio Romero-González, José Manuel Valdivielso, Pablo Molina and José L. Górriz
Nutrients 2023, 15(7), 1576; https://doi.org/10.3390/nu15071576 - 24 Mar 2023
Cited by 2 | Viewed by 4898
Abstract
Chronic kidney disease (CKD) is a highly prevalent condition worldwide in which the kidneys lose many abilities, such as the regulation of vitamin D (VD) metabolism. Moreover, people with CKD are at a higher risk of multifactorial VD deficiency, which has been extensively [...] Read more.
Chronic kidney disease (CKD) is a highly prevalent condition worldwide in which the kidneys lose many abilities, such as the regulation of vitamin D (VD) metabolism. Moreover, people with CKD are at a higher risk of multifactorial VD deficiency, which has been extensively associated with poor outcomes, including bone disease, cardiovascular disease, and higher mortality. Evidence is abundant in terms of the association of negative outcomes with low levels of VD, but recent studies have lowered previous high expectations regarding the beneficial effects of VD supplementation in the general population. Although controversies still exist, the diagnosis and treatment of VD have not been excluded from nephrology guidelines, and much data still supports VD supplementation in CKD patients. In this narrative review, we briefly summarize evolving controversies and useful clinical approaches, underscoring that the adverse effects of VD derivatives must be balanced against the need for effective prevention of progressive and severe secondary hyperparathyroidism. Guidelines vary, but there seems to be general agreement that VD deficiency should be avoided in CKD patients, and it is likely that one should not wait until severe SHPT is present before cautiously starting VD derivatives. Furthermore, it is emphasized that the goal should not be the complete normalization of parathyroid hormone (PTH) levels. New developments may help us to better define optimal VD and PTH at different CKD stages, but large trials are still needed to confirm that VD and precise control of these and other CKD-MBD biomarkers are unequivocally related to improved hard outcomes in this population. Full article
(This article belongs to the Special Issue Vitamin D Receptor in Human Health and Disease—2nd Edition)
Show Figures

Figure 1

Back to TopTop